Local Overexpression of Interleukin-11 in the Central Nervous System Limits Demyelination and Enhances Remyelination
Demyelination is one of the pathological hallmarks of multiple sclerosis (MS). To date, no therapy is available which directly potentiates endogenous remyelination. Interleukin-11 (IL-11), a member of the gp130 family of cytokines, is upregulated in MS lesions. Systemic IL-11 treatment was shown to...
Saved in:
Main Authors: | Anurag Maheshwari, Kris Janssens, Jeroen Bogie, Chris Van Den Haute, Tom Struys, Ivo Lambrichts, Veerle Baekelandt, Piet Stinissen, Jerome J. A. Hendriks, Helena Slaets, Niels Hellings |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/685317 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The phytohormone abscisic acid enhances remyelination in mouse models of multiple sclerosis
by: Femke Van Gaever, et al.
Published: (2024-12-01) -
Corrigendum: The phytohormone abscisic acid enhances remyelination in mouse models of multiple sclerosis
by: Femke Van Gaever, et al.
Published: (2025-02-01) -
Siponimod supports remyelination in the non-supportive environment
by: Johann Krüger, et al.
Published: (2025-02-01) -
Neuroborreliosis mimicking demyelinating disease of the central nervous system: case reports
by: N. Giedraitienė, et al.
Published: (2018-09-01) -
Glutamate Receptors in Neuroinflammatory Demyelinating Disease
Published: (2006-01-01)